After exclusion of patients for disease and laboratory characteristics with potential effects on CSF parameters (e.g., intraventricular hemorrhage) and for incomplete CSF parameters (e.g., albumin values in CSF and blood), 138 stroke patients remained for final analysis: 103 (74.6%) ischemic stroke and 35 (25.4%) hemorrhagic stroke patients [22]. This evidence concerns the gene ALB and hemorrhagic stroke.